Published in Osteoporos Int on June 08, 2010
Improving adherence to and persistence with oral therapy of osteoporosis. Osteoporos Int (2015) 1.46
The complex relation between bisphosphonate adherence and fracture reduction. J Clin Endocrinol Metab (2010) 0.99
Bisphosphonate prescribing, persistence and cumulative exposure in Ontario, Canada. Osteoporos Int (2011) 0.96
Vitamin D supplements with or without calcium to prevent fractures. Bonekey Rep (2014) 0.83
Accounting for unobservable exposure time bias when using Medicare prescription drug data. Medicare Medicaid Res Rev (2013) 0.82
Predictors of re-fracture amongst patients managed within a secondary fracture prevention program: a 7-year prospective study. Osteoporos Int (2014) 0.81
Methods to examine the impact of compliance to osteoporosis pharmacotherapy on fracture risk: systematic review and recommendations. Ther Adv Chronic Dis (2010) 0.80
Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management. Osteoporos Int (2014) 0.79
Why is greater medication adherence associated with better outcomes. Emerg Themes Epidemiol (2013) 0.79
Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in observational data. Arthritis Care Res (Hoboken) (2012) 0.77
Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™. Osteoporos Int (2014) 0.77
Longitudinal change in hip fracture incidence after starting risedronate or raloxifene: an observational study. J Bone Miner Metab (2011) 0.76
Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States. Osteoporos Int (2016) 0.75
Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients. Osteoporos Int (2013) 0.75
Adherence to medication. N Engl J Med (2005) 39.77
Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025. J Bone Miner Res (2007) 14.84
A meta-analysis of the association between adherence to drug therapy and mortality. BMJ (2006) 7.79
Medication compliance and persistence: terminology and definitions. Value Health (2008) 7.58
Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med (2007) 7.38
Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA (2007) 7.11
Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab (2005) 5.64
Information on cost-effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med (2008) 5.13
Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect. Am J Epidemiol (2007) 3.82
Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet (2005) 3.67
A checklist for medication compliance and persistence studies using retrospective databases. Value Health (2007) 3.64
Identification of fractures from computerized Medicare files. J Clin Epidemiol (1992) 3.26
Health beliefs, disease severity, and patient adherence: a meta-analysis. Med Care (2007) 2.59
Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47
Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis. Mayo Clin Proc (2007) 2.43
Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med (2008) 2.40
Impact of osteoporosis treatment adherence on fracture rates in North America and Europe. Am J Med (2009) 2.27
Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Fosamax International Trial Study Group. Osteoporos Int (1999) 1.98
Immeasurable time bias in observational studies of drug effects on mortality. Am J Epidemiol (2008) 1.73
Gaps in treatment among users of osteoporosis medications: the dynamics of noncompliance. Am J Med (2007) 1.62
Poor bisphosphonate adherence for treatment of osteoporosis increases fracture risk: systematic review and meta-analysis. Osteoporos Int (2009) 1.50
Correlation between patient recall of bone densitometry results and subsequent treatment adherence. Osteoporos Int (2005) 1.16
Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence. Expert Opin Pharmacother (2009) 1.10
Osteoporosis risk perceptions among patients who have sustained a fragility fracture. Patient Educ Couns (2008) 1.09
Characteristics of patients initiating raloxifene compared to those initiating bisphosphonates. BMC Womens Health (2008) 0.99
Bisphosphonates and osteoporotic fractures: a cross-design synthesis of results among compliant/persistent postmenopausal women in clinical practice versus randomized controlled trials. Osteoporos Int (2009) 0.97
'If it was osteoporosis, I would have really hurt myself.' Ambiguity about osteoporosis and osteoporosis care despite a screening programme to educate fragility fracture patients. J Eval Clin Pract (2010) 0.94
Measuring and improving adherence to osteoporosis pharmacotherapy. Curr Opin Rheumatol (2010) 0.93
What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis? Osteoporos Int (2010) 0.89
Medication adherence, first episode duration, overall duration and time without therapy: the example of bisphosphonates. Pharmacoepidemiol Drug Saf (2009) 0.86
A self-administered questionnaire for the assessment of severity of symptoms and functional status in carpal tunnel syndrome. J Bone Joint Surg Am (1993) 7.53
Variations in the use of medical and surgical services by the Medicare population. N Engl J Med (1986) 7.26
A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care (1986) 7.26
Does inappropriate use explain geographic variations in the use of health care services? A study of three procedures. JAMA (1987) 7.04
Measuring the whole or the parts? Validity, reliability, and responsiveness of the Disabilities of the Arm, Shoulder and Hand outcome measure in different regions of the upper extremity. J Hand Ther (2001) 5.10
The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc (2001) 4.99
Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum (1999) 4.46
Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health (1986) 4.42
The North American spine society lumbar spine outcome assessment Instrument: reliability and validity tests. Spine (Phila Pa 1976) (1996) 3.94
A connective tissue disease screening questionnaire for population studies. Ann Epidemiol (1995) 3.72
The appropriateness of carotid endarterectomy. N Engl J Med (1988) 3.66
Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis (2006) 3.48
Does inappropriate use explain small-area variations in the use of health care services? JAMA (1990) 3.38
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA (2000) 3.03
A taxonomy for responsiveness. J Clin Epidemiol (2001) 3.03
Short- and long-term residents of nursing homes. Med Care (1981) 2.69
Physician ratings of appropriate indications for three procedures: theoretical indications vs indications used in practice. Am J Public Health (1989) 2.63
The rational clinical examination. Does this patient have a torn meniscus or ligament of the knee? Value of the physical examination. JAMA (2001) 2.62
Predicting the appropriate use of carotid endarterectomy, upper gastrointestinal endoscopy, and coronary angiography. N Engl J Med (1990) 2.60
Consensus criteria for the classification of carpal tunnel syndrome in epidemiologic studies. Am J Public Health (1998) 2.53
Validity and responsiveness of the Knee Society Clinical Rating System in comparison with the SF-36 and WOMAC. J Bone Joint Surg Am (2001) 2.53
Gender differences in patient preferences may underlie differential utilization of elective surgery. Am J Med (1997) 2.31
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. Osteoarthritis Cartilage (2010) 2.24
"Are you better?" A qualitative study of the meaning of recovery. Arthritis Rheum (2001) 2.24
Cultural and economic factors that (mis)shape antibiotic use: the nonpharmacologic basis of therapeutics. Ann Intern Med (2000) 2.16
Measurement properties of a self-administered outcome measure in lumbar spinal stenosis. Spine (Phila Pa 1976) (1996) 2.16
Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med (2000) 2.07
Costs, outcomes, and patient satisfaction by provider type for patients with rheumatic and musculoskeletal conditions: a critical review of the literature and proposed methodologic standards. Ann Intern Med (1997) 2.06
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther (2009) 1.98
Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care (1996) 1.77
Major issues in geriatrics over the last five years. J Am Geriatr Soc (1994) 1.75
Development and preliminary psychometric testing of a new OA pain measure--an OARSI/OMERACT initiative. Osteoarthritis Cartilage (2008) 1.75
Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis. J Clin Epidemiol (1995) 1.74
Reciprocal changes in serum concentrations of 3,3',5-triiodothyronine (T3) in systemic illnesses. J Clin Endocrinol Metab (1975) 1.72
Carotid endarterectomy for elderly patients: predicting complications. Ann Intern Med (1990) 1.69
Cost-effectiveness of fusion with and without instrumentation for patients with degenerative spondylolisthesis and spinal stenosis. Spine (Phila Pa 1976) (2000) 1.68
Carpal tunnel release. Correlations with preoperative symptomatology. Clin Orthop Relat Res (1996) 1.67
In situ hybridization studies of stromelysin and collagenase messenger RNA expression in rheumatoid synovium. Arthritis Rheum (1991) 1.66
Looking for important change/differences in studies of responsiveness. OMERACT MCID Working Group. Outcome Measures in Rheumatology. Minimal Clinically Important Difference. J Rheumatol (2001) 1.64
Opposite effects of dexamethasone on serum concentrations of 3,3',5'-triiodothyronine (reverse T3) and 3,3'5-triiodothyronine (T3). J Clin Endocrinol Metab (1975) 1.64
The prognostic importance of patient pre-operative expectations of surgery for lumbar spinal stenosis. Patient Educ Couns (1998) 1.60
How coronary angiography is used. Clinical determinants of appropriateness. JAMA (1987) 1.58
Inhibition of protein kinase C by tamoxifen. Cancer Res (1985) 1.56
Classification criteria revisited. Arthritis Rheum (1991) 1.53
Measuring the clinical appropriateness of the use of a procedure. Can we do it? Med Care (1988) 1.53
Can history and physical examination be used as markers of quality? An analysis of the initial visit note in musculoskeletal care. Med Care (2000) 1.52
Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell (1989) 1.52
Cognitive function in non-demented older adults with hypothyroidism. J Am Geriatr Soc (1992) 1.51
Joint space narrowing and Kellgren-Lawrence progression in knee osteoarthritis: an analytic literature synthesis. Osteoarthritis Cartilage (2008) 1.49
American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA (1990) 1.46
Outcomes of care and resource utilization among patients with knee or shoulder disorders treated by general internists, rheumatologists, or orthopedic surgeons. Am J Med (2000) 1.45
Obtaining clinical data on the appropriateness of medical care in community practice. JAMA (1987) 1.45
Interpretation of change scores in ordinal clinical scales and health status measures: the whole may not equal the sum of the parts. J Clin Epidemiol (1996) 1.44
The total hip arthroplasty outcome evaluation form of the American Academy of Orthopaedic Surgeons. Results of a nominal group process. The American Academy of Orthopaedic Surgeons Task Force on Outcome Studies. J Bone Joint Surg Am (1991) 1.44
Geriatric medicine: a true primary care discipline. J Am Geriatr Soc (1993) 1.44
Radioimmunoassay for measurement of triiodothyronine in human serum. J Clin Invest (1971) 1.43
Total hip arthroplasty: use and select complications in the US Medicare population. Am J Public Health (1996) 1.43
Derivation of clinical indications for carotid endarterectomy by an expert panel. Am J Public Health (1987) 1.42
Comparative responsiveness of generic versus disease-specific and weighted versus unweighted health status measures in carpal tunnel syndrome. Med Care (1998) 1.39
Uric acid lowering therapy: prescribing patterns in a large cohort of older adults. Ann Rheum Dis (2007) 1.39
Women in geriatrics. J Am Geriatr Soc (1993) 1.39
Identification of subgroups of euthyroid graves's ophthalmopathy. N Engl J Med (1977) 1.38
Improving the physician role in evaluating work ability and managing disability: a survey of primary care practitioners. Disabil Rehabil (2002) 1.38
Prevalence of geriatric articles in general medical journals. J Am Geriatr Soc (1990) 1.38
Pathways of metabolism of thyroid hormones. Recent Prog Horm Res (1978) 1.37
Measuring disability of the upper extremity: a rationale supporting the use of a regional outcome measure. J Hand Ther (2000) 1.36
Inhibition of long-acting thyroid stimulator by thyroid particulate fractions. J Clin Invest (1966) 1.35
Production of antibodies specifically binding triiodothyronine and thyroxine. J Clin Endocrinol Metab (1971) 1.33
Predictors of blood loss during total hip replacement surgery. Arthritis Care Res (1995) 1.30
Measuring functional outcomes in work-related upper extremity disorders. Development and validation of the Upper Extremity Function Scale. J Occup Environ Med (1997) 1.30
Thyroxine: just a prohormone or a hormone too? J Clin Endocrinol Metab (1973) 1.29
The self-administered patient satisfaction scale for primary hip and knee arthroplasty. Arthritis (2011) 1.29
Measuring relevant change: an emerging challenge in rheumatologic clinical trials. Arthritis Rheum (1995) 1.28
Maine Carpal Tunnel Study: small area variations. J Hand Surg Am (1998) 1.26
Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review. Osteoarthritis Cartilage (2011) 1.24
Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease. Am J Med (1967) 1.24
Forecasting the burden of advanced knee osteoarthritis over a 10-year period in a cohort of 60-64 year-old US adults. Osteoarthritis Cartilage (2010) 1.24
A randomized controlled trial of mailed osteoporosis education to older adults. Osteoporos Int (2006) 1.22
Development and testing of a reduced WOMAC function scale. J Bone Joint Surg Br (2003) 1.22
Examination findings and self-reported walking capacity in patients with lumbar spinal stenosis. Phys Ther (2001) 1.19
Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes. J Clin Endocrinol Metab (1968) 1.19
The use and misuse of upper gastrointestinal endoscopy. Ann Intern Med (1988) 1.19
In search of an inhibitor of thyroid hormone binding to serum proteins in nonthyroid illnesses. J Clin Endocrinol Metab (1979) 1.19
Patterns of drug use in rheumatoid arthritis. J Rheumatol (2000) 1.16
Alterations in circulating thyroid hormones and thyrotropin in hepatic cirrhosis: evidence for euthyroidism despite subnormal serum triiodothyronine. J Clin Endocrinol Metab (1974) 1.15
How many physicians will be needed to provide medical care for older persons? Physician manpower needs for the twenty-first century. J Am Geriatr Soc (1993) 1.15
A review of health-related work outcome measures and their uses, and recommended measures. Spine (Phila Pa 1976) (2000) 1.15
Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review. Osteoporos Int (2009) 1.14
Graves' disease--1972. Mayo Clin Proc (1972) 1.13
Thyroxine and triiodothyronine in the human thyroid. J Clin Endocrinol Metab (1973) 1.13
The Short Form-36 is preferable to the SIP as a generic health status measure in patients undergoing elective total hip arthroplasty. Arthritis Care Res (1995) 1.13
Outcomes in work-related upper extremity and low back injuries: results of a retrospective study. Am J Ind Med (2000) 1.12
Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease. J Clin Endocrinol Metab (1976) 1.12
A radioimmunoassay of thyroxine. J Clin Endocrinol Metab (1971) 1.12
Nonoccupational risk factors for carpal tunnel syndrome. J Gen Intern Med (1999) 1.11
Basal joint arthritis: trapeziectomy with ligament reconstruction and tendon interposition arthroplasty. J Hand Surg Am (1996) 1.09
Selecting target conditions for quality of care improvement in vulnerable older adults. J Am Geriatr Soc (2000) 1.09